Q4 2016

Filed Mar 15, 2017 · 10-K · 74 days after period end · 0001144204-17-014602

Q4 2016 · 10-K

Revenue

$13.00K

— vs Q4 2015

Net Income

-$1.37M

N/M vs Q4 2015

EPS Diluted

-$0.01

N/M vs Q4 2015

Operating Income-$1,668,000N/M

Operating Cash Flow

Same quarter

Metric	Q4 2016	Q4 2015	Q4 2014	Q4 2013
Revenue	$13.00K	$0.00	$0.00	$0.00
Net Income	-$1.37M	-$1.46M	-$1.60M	-$789.56K
EPS Diluted	-$0.01	-$0.02	-$0.02	-$0.01

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR